I see your point. I think within a couple weeks we'll be
I see your point. I think within a couple weeks we'll be putting shorts in an even harder position. The bs they are spewing holds nothing valid. Fundamentals continue to escalate. Leo is coming through for us. I also completely understand the frustration many have expressed, including Drano. I have seen many tactics over the years of malicious shorting holding back a company. They've messed with the wrong company this time. There are no funding issues and science is proving to move forward. Not to mention the completely non toxic arrangements Cellceutix has access to through 2016. Companies I've seen drug through similar short attacks that drag on end up succumbing to very dilutive financing and just can't recover. This is in no way happening here. The more vigilant we can be in fighting fire with fire is to stay the course and reply with fact after fact straight from the company staying on topic. We know what we own.
I am invested in another company that has one of the highest short interest ratios, NAVB. Over 30M shares short with around 55 days to cover. How does that happen? Hedge funds that have the capital not to sweat a share price fluctuation of even $1. Fortunately for me this one has been one of my best bottom plays but similarly to Cellceutix, there are many that bought higher and find their due diligence tested to the limits.
We can't ignore what people say about shorts, we can simply rub facts in their face for as long as it takes. Stay on topic, keep it about the company.
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...
Continue Reading
Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...
Continue Reading
FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...
Continue Reading
Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...
Continue Reading
Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...
Continue Reading
If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...
Continue Reading
A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...
Continue Reading
Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...
Continue Reading
Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...
Continue Reading
China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...
Continue Reading
Top 5 Most Recently Viewed Articles
NexGen Hyperbaric Partners with Philadelphia Flyers NexGen Hyperbaric is excited to announce a new collaboration with the Philadelphia Flyers, becoming the first franchise in the NHL to adopt hyperbaric oxygen therapy (HBOT) into their wellness strategy. This partnership aims to enhance the health and performance of both current athletes and former players, showcasing a...
Continue Reading
The US Dollar Gains Traction The US Dollar has seen significant gains lately, buoyed by rising Treasury yields that indicate a shift in market dynamics. As speculation continued about the future of the Federal Reserve Chair, the Dollar strengthened against various currencies. This month, the Dollar has been on a rally, indicating a robust performance against major...
Continue Reading
Eve Air Mobility's Significant Equity Raise Eve Air Mobility (NYSE: EVEX) has recently made headlines with its ambitious plan to raise $230 million through a registered direct offering. This initiative is designed to enhance the company’s efforts in the Urban Air Mobility (UAM) sector, showcasing their commitment to advancing eVTOL aircraft technology. Subscription...
Continue Reading
Market Reaction to PDD Holdings Recently, PDD Holdings (NASDAQ: PDD) faced some market pressure, even though there was no significant news from the company. Following their earnings release, several analysts lowered their price targets, which triggered a noticeable sell-off in the market. PDD's American depositary receipts (ADRs) dropped by more than 4%, in stark contrast...
Continue Reading
Progenity Inc's Stock Hits Record Low In a year fraught with challenges, Progenity Inc has found itself grappling with a steep decline in stock prices, reaching a worrying 52-week low of $0.47. The biotech company, noted for its innovative health solutions, has seen its stock value plunge by an alarming 77.71% over the year. Investors have been anxious as the company...
Continue Reading